Detalhe da pesquisa
1.
Vitamin D did not reduce multiple sclerosis disease activity after a clinically isolated syndrome.
Brain
; 147(4): 1206-1215, 2024 Apr 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38085047
2.
Oral corticosteroid dosage and taper duration at onset in myelin oligodendrocyte glycoprotein antibody-associated disease influences time to first relapse.
J Neurol Neurosurg Psychiatry
; 2024 May 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38744459
3.
The MOG antibody non-P42 epitope is predictive of a relapsing course in MOG antibody-associated disease.
J Neurol Neurosurg Psychiatry
; 95(6): 544-553, 2024 May 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38290838
4.
Changes in employment status over time in multiple sclerosis following a first episode of central nervous system demyelination, a Markov multistate model study.
Eur J Neurol
; 31(1): e16016, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37525323
5.
Genetically determined serum serine level has a novel causal effect on multiple sclerosis risk and predicts disability progression.
J Neurol Neurosurg Psychiatry
; 94(7): 526-531, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36732044
6.
A pro-inflammatory diet in people with multiple sclerosis is associated with an increased rate of relapse and increased FLAIR lesion volume on MRI in early multiple sclerosis: A prospective cohort study.
Mult Scler
; 29(8): 1012-1023, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37148166
7.
Long-term trajectories of employment status, workhours and disability support pension status, after a first episode of CNS demyelination.
Mult Scler
; 28(11): 1793-1807, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35549477
8.
Magnetic resonance imaging in neuromyelitis optica spectrum disorder.
Clin Exp Immunol
; 206(3): 251-265, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34080180
9.
Efficacy of alemtuzumab over 6 years in relapsing-remitting multiple sclerosis patients who relapsed between courses 1 and 2: Post hoc analysis of the CARE-MS studies.
Mult Scler
; 26(13): 1719-1728, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31675266
10.
Effects of cannabinoids in Amyotrophic Lateral Sclerosis (ALS) murine models: a systematic review and meta-analysis.
J Neurochem
; 149(2): 284-297, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30520038
11.
Leasing a medical curriculum: What's it worth?
Med Teach
; 41(6): 697-702, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30736709
12.
Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination.
J Neurol Neurosurg Psychiatry
; 89(2): 127-137, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29142145
13.
Adopting genetics: motivations and outcomes of personal genomic testing in adult adoptees.
Genet Med
; 18(9): 924-32, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-26820063
14.
Genetic variants are major determinants of CSF antibody levels in multiple sclerosis.
Brain
; 138(Pt 3): 632-43, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25616667
15.
Regulatory T, natural killer T and γδ T cells in multiple sclerosis and chronic fatigue syndrome/myalgic encephalomyelitis: a comparison.
Asian Pac J Allergy Immunol
; 34(4): 300-305, 2016 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-27001659
16.
A new era in the treatment of multiple sclerosis.
Med J Aust
; 203(3): 139-41, 141e.1, 2015 Aug 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-26224184
17.
Longlook: initial outcomes of a longitudinal integrated rural clinical placement program.
Aust J Rural Health
; 23(3): 169-75, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25981882
18.
Ribosomal protein S6 mRNA is a biomarker upregulated in multiple sclerosis, downregulated by interferon treatment, and affected by season.
Mult Scler
; 20(6): 675-85, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24126065
19.
Enhancing cognitive-behavioural therapy for recurrent headache: design of a randomised controlled trial.
BMC Neurol
; 14: 233, 2014 Dec 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-25496514
20.
Comparative efficacy of ofatumumab versus oral therapies for relapsing multiple sclerosis patients using propensity score analyses and simulated treatment comparisons.
Ther Adv Neurol Disord
; 17: 17562864241239453, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38525490